Towards an effective HIV vaccine by Rogier Sanders and Godelieve de Bree (Amsterdam UMC)
There is not yet a vaccine against the second deadliest infection in the world after tuberculosis: HIV. Rogier Sanders and Godelieve de Bree of the Amsterdam UMC are optimistic about the possibility of developing one now. It’s for the first time that a vaccine is being developed in one hospital (Amsterdam UMC) from the design phase to the safety and efficacy studies in healthy volunteers. It’s also unique that these studies for an HIV vaccine are being done in the Netherlands.
However, actually making the vaccine for testing in humans is very expensive. Rogier and Godelieve are trying to make that happen and are now looking for funding. The potential impact on treating HIV through this vaccine is enormous!
Explore other Stories:
Story of Maaike van Rest (VU Amsterdam)
How to make an impact with your research and what does it take to go from idea to product or service. Watch the video of Maaike van Rest. Maaike explains what has helped her to bring an idea to the market in the shape of a product.
Biobanks crucial for novel diagnostics or therapeutics
Biobanks contain valuable information on the donor of the sample. Access to these collections can be crucial for companies developing novel diagnostics or therapeutics.
More effective surgery through improved alignment of bone segments
Iwan Dobbe is bringing the benefits of modern 3D image analysis and printing technology to the clinic. As a researcher at the Biomedical Engineering and Physics department at AMC he devised a method for the design and production of a patient-specific plate for the alignment of bone segments. It requires a single CT scan, preoperative […]